Abstract:Background/aim: During the last two decades, Parkinson's disease (PD)-associated genes have been associated with cancer; however, a shared pathogenic mechanism has yet to be discovered. Parkin, an E3 ubiquitin ligase that is involved in early-onset Parkinson's disease, has also been reported to exert tumor suppressor activity. However, the details about the role of Parkin in cancer remain unknown. The present study aimed at identifying differentially regulated nuclear proteins and nuclear phosphoproteins whose levels were affected by Parkin expression. Materials and methods: SHS-SY5Y cells expressing either wild-type Parkin or its mutant under tetracycline control were used in this study; cells not expressing Parkin served as control. Nuclear proteins were enriched from Parkin-expressing and control cells to perform a comparative proteomics study using two-dimensional gel electrophoresis (2D) coupled to matrix assisted laser desorption/ionisation-time of flight (MALDI-TOF/TOF) mass spectrometry analysis. Changes in phosphoproteome and nuclear phosphoproteome were also studied by staining the 2D gels with ProQ diamond phosphoprotein stain. The identified proteins were subjected to bioinformatics analysis to elucidate the reactomes and relevant pathways. Results: Six nuclear proteins, namely NCL, DDIT3, PARP1, HMGB1, TCTP and TPI were shown to be differentially regulated in cells expressing Parkin protein. Regulations in phosphorylation levels of ENPL, PRDX4, ECHM, ALDOA SET, DHSA, RCC1 and DULRD were also detected. Bioinformatics analysis of differentially regulated proteins highlighted the involvement of Parkin in DNA repair. Conclusion: Several nuclear protein candidates whose expression or phosphorylation levels were altered in cells expressing Parkin. Bioinformatics analysis of these proteins indicated that the nuclear form of Parkin may play a significant role in DNA repair and contribute to prevention of tumorogenesis via maintaining DNA integrity.

Parkin activates innate immunity and promotes anti-tumor immune responses

Parkin paves the path to antitumor immunity: Expanding Parkin's role as a tumor suppressor

Parkin Exerts the Tumor‐suppressive Effect Through Targeting Mitochondria

Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression

Parkin, A P53 Target Gene, Mediates the Role of P53 in Glucose Metabolism and the Warburg Effect

The tumor suppressor Parkin exerts anticancer effects through regulating mitochondrial GAPDH activity

Investigation of the Involvement of Parkin in Parkinson's Disease and Cancer by Monitoring the Changes in SH-SY5Y Cells at the Nuclear Proteome Level

Inactivating the Ubiquitin Ligase Parkin Suppresses Cell Proliferation and Induces Apoptosis in Human Keloids.

Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease

Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression

Somatic and Germline Mutations in the Tumor Suppressor Gene PARK2 Impair PINK1/Parkin-mediated Mitophagy in Lung Cancer Cells

Parkin deficiency promotes liver cancer metastasis by TMEFF1 transcription activation via TGF-β/Smad2/3 pathway

Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation.

Parkinson's Disease-Associated Protein Parkin: an Unusual Player in Cancer

Parkin induces upregulation of 40S ribosomal protein SA and posttranslational modification of cytokeratins 8 and 18 in human cervical cancer cells

Parkin induces apoptotic cell death in TNF-α-treated cervical cancer cells

Parkin Regulates Mitosis and Genomic Stability Through Cdc20/Cdh1.

Parkin Regulates Paclitaxel Sensitivity in Breast Cancer Via A Microtubule-Dependent Mechanism

Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer

Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy

Parkin inhibits proliferation and migration of bladder cancer via ubiquitinating Catalase